Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis

Oncogene

Volumn 21, Issue 53, 2002, Pages 8149-8157

  Shchepina, Liarisa A ^a   Pletjushkina, Olga Y ^a   Avetisyan, Armine V ^a   Bakeeva, Liora E ^a   Fetisova, Elena K ^a   Izyumov, Denis S ^a   Saprunova, Valeria B ^a   Vyssokikh, Mikhail Yu ^a   Chernyak, Boris V ^a   Skulachev, Vladimir P ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Apoptosis; Bcl 2; Membrane potential; Mitochondria; Oligomycin; Permeability transition; Tumor necrosis factor; Ultrastructure

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE TRIPHOSPHATE; AUROVERTIN; AUROVERTIN A; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CYCLOSPORIN A; CYTOCHROME C; OLIGOMYCIN; PROTEIN BCL 2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; STAUROSPORINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUROVERTIN B; CARRIER PROTEIN; CYCLOSPORIN; DEOXYGLUCOSE; EMETINE; ENZYME INHIBITOR; HYBRID PROTEIN; ION CHANNEL; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; RECOMBINANT PROTEIN; TUMOR PROTEIN; UNCOUPLING PROTEIN;

APOPTOSIS; ARTICLE; DRUG MECHANISM; HELA CELL; HUMAN; HUMAN CELL; HYDROLYSIS; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL MEMBRANE POTENTIAL; CYTOSOL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; METABOLISM; MITOCHONDRION; PHYSIOLOGY; PROTO ONCOGENE;

AUROVERTINS; CYCLOSPORINE; CYTOCHROME C GROUP; CYTOSOL; DEOXYGLUCOSE; EMETINE; ENZYME INHIBITORS; GENES, BCL-2; HELA CELLS; HUMANS; ION CHANNELS; MEMBRANE POTENTIALS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NEOPLASM PROTEINS; OLIGOMYCINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTON-TRANSLOCATING ATPASES; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; STAUROSPORINE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UNCOUPLING AGENTS;

EID: 18744390391     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206053     Document Type: Article

References (38)

1. Bradham CA, Qian T, Streetz K, Tratwein C, Brenner DA and Lemasters JJ. (1998). Mol. Cell. Biol., 18, 6353-6364.
2. Broekemeier KM and Pfeiffer DR. (1995). Biochemistry, 34, 16440-16449.
3. Domnina LV, Ivanova OY, Chernyck BV, Skulachev VP and Vasiliev YM. (2002). Biochemistry (Moscow), 67, 737-746.
4. Du C, Fang M, Li Y, Li L and Wang X. (2000). Cell, 102, 33-42.
5. Eguchi Y, Shimizu S and Tsujimoto Y. (1997). Cancer Res., 57, 1835-1840.
6. Goldstein JC, Waterhouse NJ, Juin P, Evans GI and Green DR. (2000). Nature Cell. Biol., 2, 156-162.
7. Hsu YT, Walter KG and Joule RJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 3668-3672.
8. Ikemoto H, Tani E, Ozaki I, Kitagawa H and Arita N. (2000). Cell Death Diff., 7, 511-520.
9. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD. (1997). Science, 275, 1132-1136.
10. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ and Shlesinger PH. (2000). Cell Death Diff., 7, 1166-1173.
11. Kroemer G. (1997). Nature Med., 3, 614-620.
12. Kroemer G, Dallaporta B and Reshe-Rigon M. (1998). Ann. Rev. Physiol., 60, 619-642.
13. Kroemer G and Reed JC. (2000). Nature Med., 6, 513-519.
14. Leist M, Single B, Castoldi AF, Kuhnle S and Nicotera P. (1997). J. Exp. Med., 185, 1481-1486.
15. Li LY, Luo X and Wang X. (2001). Nature, 412, 95-99.
16. Liu Y, Peterson DA, Kimura H and Schubert D. (1997). J. Neurochem., 69, 581-593.
17. Matsuyama S, Xu Q, Velours J and Reed JC. (1998). Mol. Cell, 1, 327-336.
18. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H and Tsujimoto Y. (1998). Proc. Natl. Acad. Sci. USA, 95, 14681-14686.
19. Novgorodov SA, Gudz TI, Mohr Yu E, Goncharenko EN and Yaguzhinsky LS. (1989). FEBS Lett., 247, 255-258.
20. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B and Orrenius S. (2002). Proc. Natl. Acad. Sci. USA, 99, 1259-1263.
21. Peachman KK, Lyles DS and Bass DA. (2001). Proc. Natl. Acad. Sci. USA, 98, 1717-1722.
22. Salomon AR, Voehringer DW, Herzenberg LA and Khosla C. (2000). Proc. Natl. Acad. Sci. USA, 97, 14766-14771.
23. Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S. (1999). EMBO J., 18, 2040-2048.
24. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA and Korsmeyer SJ. (2002). Dev. Cell, 2, 55-67.
25. Shchepina LA, Popova EN, Pletjushkina OYu and Chernyak BV. (2002). Biochemistry (Moscow), 67, 222-226.
26. Sidoti-de Fraisse C, Rincheval V, Risler Y, Mignotte B and Vayssiere J-L. (1998). Oncogene, 17, 1639-1651.
27. Skulachev VP. (1996a). FEBS Lett., 397, 7-10.
28. Skulachev VP. (1996b). Quart. Rev. Biophys., 29, 169-202.
29. Skulachev VP. (1998). FEBS Lett., 423, 275-280.
30. Skulachev VP. (1999). Mol. Asp. Med., 20, 139-184.
31. Tafani M, Minchenko DA, Serroni A and Farber JL. (2001). Cancer Res., 61, 2459-2466.
32. Tafani M, Schneider TG, Pastorino JG and Farber JL. (2000). Am. J. Physiol., 156, 2111-2121.
33. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT and Thompson CB. (1997). Cell, 91, 627-637.
34. Verhagen AM, Ekert PG, Pakush M, Silke J, Connoly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL. (2000). Cell, 102, 45-53.
35. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB and Korsmeyer SJ. (2000). Genes Dev., 14, 2060-2071.
36. Wolvetang EJ, Johnson KL, Krauer K, Ralph SJ and Linnane AW. (1994). FEBS Lett., 339, 40-44.
37. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng II, Jones DP and Wang X. (1997). Science, 275, 1129-1132.
38. Zhuang J, Dinsdale D and Cohen GM. (1998). Cell Death Diff., 5, 953-962.